Study barriers, variation, and opportunities to optimize biomarker testing for NSCLC at the point of diagnosis.
Key Activities
Working groups on topics including: 14-Day Rule Reform, Healthcare System Implementation, Society Collaboration, Payers and Coverage, Data Gathering, and Terminology Definition. Past work includes landscape assessment on provider perspective on pathologist role in ordering biomarker panels, solutions roadmap of strategies health systems use for timely testing, and analysis of 14-day rule on biomarker testing timelines. Co-developed materials providing overview of May 2024 MolDx clarification on CMS 'treating physician' guidance; distributed to hospital administrators.